Results 161 to 170 of about 11,014 (213)

Development of an intraductal papillary mucinous neoplasm malignancy prediction scoring system. [PDF]

PLoS One
Kobayashi M, Katsuda H, Maekawa A, Akahoshi K, Watanabe R, Kinowaki Y, Nishimura H, Fujiwara T, Tanabe M, Okamoto R.   +9 more
europepmc   +1 more source

Spleen-preserving distal pancreatectomy for intraductal papillary mucinous neoplasm. [PDF]

Gland Surg
Sakamoto K.
europepmc   +1 more source

International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas: what is the breaking news? [PDF]

Hepatobiliary Surg Nutr
Sperti C, Belluzzi A.
europepmc   +1 more source

Rescue therapy for recurrent cholangitis secondary to main duct intraductal papillary mucinous neoplasm with pancreatobiliary fistula using an esophageal fully covered metal stent. [PDF]

Endoscopy
Lim-Fernandez AK, Lim SJM, Khor CJL, Tan DMY.   +3 more
europepmc   +1 more source

Absence of a pancreatic microbiome in intraductal papillary mucinous neoplasm. [PDF]

Gut
Pust MM, Rocha Castellanos DM, Rzasa K, Dame A, Pishchany G, Assawasirisin C, Liss A, Fernandez-Del Castillo C, Xavier RJ.   +8 more
europepmc   +1 more source

Intraductal papillary mucinous neoplasm originating from a heterotopic pancreas within the stomach. [PDF]

Endosc Ultrasound
Liu M, An W, Gao J, Shi X.
europepmc   +1 more source

Intraductal Papillary Mucinous Neoplasm

Journal of Insurance Medicine, 2016
Intraductal papillary mucinous neoplasms are cystic growths often noted incidentally in the pancreatic ducts. Left untreated, some may progress to invasive cancer.
David S. Williams
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Pathology of intraductal papillary mucinous neoplasms

Langenbeck's Archives of Surgery, 2021
Intraductal papillary mucinous neoplasms (IPMNs) represent a unique opportunity to treat and prevent a curable neoplasm before it has the chance to progress to incurable cancer. This prospect, however, has to be balanced with the real risk of over treating patients with lesions that would, in fact, never progress during the life of the patient.Informed
Naziheh Assarzadegan, Elizabeth Thompson, Kevan Salimian, Matthias M. Gaida, Lodewijk A.A. Brosens, Laura Wood, Syed Z. Ali, Ralph H. Hruban   +7 more
openaire   +2 more sources

Intraductal Papillary Mucinous Neoplasms

Gastrointestinal Endoscopy Clinics of North America, 2008
Intraductal papillary mucinous neoplasm (IPMN) is characterized by enhanced mucus secretion. It is a benign or low-grade neoplasm associated with a dilated main pancreatic duct, patulous ampullary orifice, and abundant mucus secretion. Foci of aggressive cancer may arise and become invasive.
D. Nehra, M. Mino-Kenudson, S. P. Thayer, C. R. Ferrone, D. Finkelstein, M. Silver, A. L. Warshaw, C. Fernandez del-Castillo   +7 more
openaire   +3 more sources

Intraductal papillary mucinous neoplasms

Current Opinion in Gastroenterology, 2015
Our understanding of intraductal papillary mucinous neoplasm (IPMN) of the pancreas has remarkably grown within the last decade; nonetheless there is still an ongoing controversy if the majority of these potentially malignant neoplasms need to be resected or if observation in a subset is well tolerated.Novel cyst fluid biomarkers, like Gnas mutations ...
Klaus, Sahora, Carlos, Fernández-del Castillo   +1 more
openaire   +2 more sources